Biodexa Pharmaceuticals plc American Depositary Shs — Chart, Price & News (NASDAQ:BDRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Market Capitalization N/A
Employee 13
Founded 2000
CEO N/A
Website www.biodexapharma.com
Headquarter United Kingdom
FIGI BBG00BLVW2R4
Industry Technology

— Market capitalization

News

Biodexa Licenses Phase 1-Ready Drug Candidate From Otsuka For Rare Stomach Cancer - Biodexa Pharmaceuticals (NASDAQ:BDRX), Cogent Biosciences (NASDAQ:COGT)

Biodexa licenses Otsuka’s molecular glue compound for GIST treatment

Biodexa pharmaceuticals appoints Fiona Sharp as CFO and board member

Biodexa Pharmaceuticals stock falls after $10 million public offering

Biodexa prices $10 million public offering of units and warrants

Biodexa prices $10 million public offering to fund development programs

Why B. Riley Financial Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket - Adagio Medical Holdings (NASDAQ:ADGM), Aldeyra Therapeutics (NASDAQ:ALDX)

U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.37%

Why Mama's Creations Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket - Senmiao Technology (NASDAQ:AIHS), Alexander & Baldwin (NYSE:ALEX)

Biodexa enrolls first European patients in phase 3 FAP trial

Biodexa activates first European site for phase 3 FAP trial

Biodexa receives EMA approval for phase 3 FAP treatment trial